These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25317525)

  • 1. Perceptions by pregnant and childbearing-age women in southern Brazil towards teratogenic risk from medicines and radiotherapy.
    Pons Eda S; Pizzol Tda S; Knauth DR
    Cad Saude Publica; 2014 Sep; 30(9):1965-76. PubMed ID: 25317525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.
    Widnes SF; Schjøtt J; Eide GE; Granas AG
    Drug Saf; 2013 Jun; 36(6):481-9. PubMed ID: 23539202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of medicine use among pregnant women: an interview-based study.
    Nyholm RS; Andersen JT; Vermehren C; Kaae S
    Int J Clin Pharm; 2019 Aug; 41(4):1021-1030. PubMed ID: 31104187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perception of teratogenic risk of common medicines.
    Sanz E; Gómez-López T; Martínez-Quintas MJ
    Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):127-31. PubMed ID: 11267734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk management of teratogenic medicines: A systematic review.
    Shroukh WA; Steinke DT; Willis SC
    Birth Defects Res; 2020 Dec; 112(20):1755-1786. PubMed ID: 32918401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pregnant women's health literacy on their health-promoting lifestyle and teratogenic risk perception.
    Sahin E; Yesilcinar I; Geris R; Pasalak SI; Seven M
    Health Care Women Int; 2021; 42(4-6):598-610. PubMed ID: 32744890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' Perception of Teratogenic Risk and Confidence in Prescribing Drugs in Pregnancy-Influence of Norwegian Drug Information Centers.
    Bakkebø T; Widnes SF; Aamlid SS; Schjøtt J
    Clin Ther; 2016 May; 38(5):1102-8. PubMed ID: 26973297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk perception and medicines information needs in pregnant women with epilepsy--a qualitative study.
    Widnes SF; Schjøtt J; Granas AG
    Seizure; 2012 Oct; 21(8):597-602. PubMed ID: 22762859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk perception regarding drug use in pregnancy.
    Widnes SF; Schjøtt J
    Am J Obstet Gynecol; 2017 Apr; 216(4):375-378. PubMed ID: 27988271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skewed risk perceptions in pregnant women: the case of influenza vaccination.
    Bödeker B; Betsch C; Wichmann O
    BMC Public Health; 2015 Dec; 16():1308. PubMed ID: 26965449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's perspectives on counseling about risks for medication-induced birth defects.
    Santucci AK; Gold MA; Akers AY; Borrero S; Schwarz EB
    Birth Defects Res A Clin Mol Teratol; 2010 Jan; 88(1):64-9. PubMed ID: 19637252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of reproductive life plans in identification of potentially teratogenic medication use: A pilot study.
    DiPietro Mager N; Mills C; Snelling A
    Birth; 2018 Mar; 45(1):50-54. PubMed ID: 29052257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005-2015.
    Donald S; Sharples K; Barson D; Horsburgh S; Parkin L
    Eur J Clin Pharmacol; 2020 Jun; 76(6):887-896. PubMed ID: 32248249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counselling pregnant women at the crossroads of Europe and Asia: effect of Teratology Information Service in Turkey.
    Kaplan YC; Karadaş B; Küçüksolak G; Ediz B; Demir Ö; Sozmen K; Nordeng H
    Int J Clin Pharm; 2017 Aug; 39(4):783-790. PubMed ID: 28626851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of prescription medicines in Australian women of child-bearing age.
    Gadzhanova S; Roughead E
    BMC Pharmacol Toxicol; 2015 Dec; 16():33. PubMed ID: 26643036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perception of pregnant Japanese women regarding the teratogenic risk of medication exposure during pregnancy and the effect of counseling through the Japan drug information institute in pregnancy.
    Yakuwa N; Nakajima K; Koinuma S; Goto M; Suzuki T; Ito N; Watanabe O; Murashima A
    Reprod Toxicol; 2018 Aug; 79():66-71. PubMed ID: 29885359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.
    Demailly R; Escolano S; Quantin C; Tubert-Bitter P; Ahmed I
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1126-1134. PubMed ID: 28758270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma.
    Powell H; McCaffery K; Murphy VE; Hensley MJ; Clifton VL; Giles W; Gibson PG
    J Asthma; 2011 Dec; 48(10):1032-40. PubMed ID: 22091740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives of primary care clinicians on teratogenic risk counseling.
    Schwarz EB; Santucci A; Borrero S; Akers AY; Nikolajski C; Gold MA
    Birth Defects Res A Clin Mol Teratol; 2009 Oct; 85(10):858-63. PubMed ID: 19591115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals.
    Pole M; Einarson A; Pairaudeau N; Einarson T; Koren G
    J Clin Pharmacol; 2000 Jun; 40(6):573-7. PubMed ID: 10868307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.